A vulnerability index for COVID-19: spatial analysis at the subnational level in Kenya
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (ScreenIT)
Abstract
Response to the coronavirus disease 2019 (COVID-19) pandemic calls for precision public health reflecting our improved understanding of who is the most vulnerable and their geographical location. We created three vulnerability indices to identify areas and people who require greater support while elucidating health inequities to inform emergency response in Kenya.
Methods
Geospatial indicators were assembled to create three vulnerability indices; Social VulnerabilityIndex (SVI), Epidemiological Vulnerability Index (EVI) and a composite of the two, that is, Social Epidemiological Vulnerability Index (SEVI) resolved at 295 subcounties in Kenya. SVI included 19 indicators that affect the spread of disease; socioeconomic deprivation, access to services and population dynamics, whereas EVI comprised 5 indicators describing comorbidities associated with COVID-19 severe disease progression. The indicators were scaled to a common measurement scale, spatially overlaid via arithmetic mean and equally weighted. The indices were classified into seven classes, 1–2 denoted low vulnerability and 6–7, high vulnerability. The population within vulnerabilities classes was quantified.
Results
The spatial variation of each index was heterogeneous across Kenya. Forty-nine northwestern and partly eastern subcounties (6.9 million people) were highly vulnerable, whereas 58 subcounties (9.7 million people) in western and central Kenya were the least vulnerable for SVI. For EVI, 48 subcounties (7.2 million people) in central and the adjacent areas and 81 subcounties (13.2 million people) in northern Kenya were the most and least vulnerable, respectively. Overall (SEVI), 46 subcounties (7.0 million people) around central and southeastern were more vulnerable, whereas 81 subcounties (14.4 million people) were least vulnerable.
Conclusion
The vulnerability indices created are tools relevant to the county, national government and stakeholders for prioritisation and improved planning. The heterogeneous nature of the vulnerability indices underpins the need for targeted and prioritised actions based on the needs across the subcounties.
Article activity feed
-
-
SciScore for 10.1101/2020.05.27.20113803: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
NIH rigor criteria are not applicable to paper type.Table 2: Resources
Software and Algorithms Sentences Resources They include underlying medical conditions such as liver disease, chronic kidney disease, obesity, hypertension, diabetes, smoking, cardiovascular disease, chronic respiratory disease, cancer and people who are immunocompromised including HIV/AIDS [18,27-30]. HIV/AIDSsuggested: NoneThe analysis and visualizations were done using StataCorp. 2014 [Stata Statistical Software: StataCorpsuggested: (Stata, RRID:SCR_012763)College Station, TX: StataCorp LP], R software (version 3·4·1) and ArcMap 10·5 ArcMapsuggested: NoneResults from OddPub: Thank you for sharing your data.
Results from LimitationR…SciScore for 10.1101/2020.05.27.20113803: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
NIH rigor criteria are not applicable to paper type.Table 2: Resources
Software and Algorithms Sentences Resources They include underlying medical conditions such as liver disease, chronic kidney disease, obesity, hypertension, diabetes, smoking, cardiovascular disease, chronic respiratory disease, cancer and people who are immunocompromised including HIV/AIDS [18,27-30]. HIV/AIDSsuggested: NoneThe analysis and visualizations were done using StataCorp. 2014 [Stata Statistical Software: StataCorpsuggested: (Stata, RRID:SCR_012763)College Station, TX: StataCorp LP], R software (version 3·4·1) and ArcMap 10·5 ArcMapsuggested: NoneResults from OddPub: Thank you for sharing your data.
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
-